Your browser doesn't support javascript.
loading
Immune modulation of pathologic complete response after neoadjuvant HER2-directed therapies in the NeoSphere trial.
Bianchini, G; Pusztai, L; Pienkowski, T; Im, Y-H; Bianchi, G V; Tseng, L-M; Liu, M-C; Lluch, A; Galeota, E; Magazzù, D; de la Haba-Rodríguez, J; Oh, D-Y; Poirier, B; Pedrini, J L; Semiglazov, V; Valagussa, P; Gianni, L.
Affiliation
  • Bianchini G; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Pusztai L; Medical Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, USA.
  • Pienkowski T; Centrum Onkologii, Warsaw, Poland.
  • Im YH; Department of Medicine, Samsung Medical Center, Seoul, Republic of Korea.
  • Bianchi GV; Oncologia Medica, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Tseng LM; Taipei-Veterans General Hospital, National Yang-Ming University, Taipei.
  • Liu MC; Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan.
  • Lluch A; Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, Valencia, Spain.
  • Galeota E; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Magazzù D; Fondazione Michelangelo, Milan, Italy.
  • de la Haba-Rodríguez J; Hospital Reina Sofia, Córdoba, Spain.
  • Oh DY; Division of Medical Oncology, Seoul National University Hospital Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Poirier B; Centre des maladies du sein, Hôpital du Saint-Sacrement, CHU de Québec, Québec, Canada.
  • Pedrini JL; Hospital Ernesto Dornelles, Porto Alegre, Brazil.
  • Semiglazov V; NN Petrov Research Institute of Oncology, St Petersburg, Russia.
  • Valagussa P; Fondazione Michelangelo, Milan, Italy.
  • Gianni L; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy gianni.luca@hsr.it.
Ann Oncol ; 26(12): 2429-36, 2015 Dec.
Article in En | MEDLINE | ID: mdl-26387142

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Receptor, ErbB-2 / Neoadjuvant Therapy / Antibodies, Monoclonal Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2015 Document type: Article Affiliation country: Italia Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Receptor, ErbB-2 / Neoadjuvant Therapy / Antibodies, Monoclonal Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2015 Document type: Article Affiliation country: Italia Country of publication: Reino Unido